Stockreport

Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading [Yahoo! Finance]

HONG KONG EX&CL UNSP/ADR  (HKXCY) 
NASDAQ:AMEX Investor Relations: hkexgroup.com/investor-relations?sc_lang=en
PDF HANGZHOU, China March 31, 2026 /PRNewswire/ -- Hangzhou Diagens Biotechnology Co., Ltd. (HKEX: 02526) today began trading on the Main Board of The Stock Exchange of Hon [Read more]